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ABSTRACT
Endothelial cells obtained from the aortae of 1- to 2-d-old calves were cloned at
high efficiency using fibrin-coated dishes. Primary cultures as well as clones
derived from them produced high fibrinolytic activity when grown on
125
1-fibrin-
coated dishes which was 90% dependent upon the presence of plasminogen . High
plasminogen-dependent proteolytic activity was also demonstrated in endothelial
cell lysates and in the culture medium of the cells . The production and secretion
of the plasminogen activator(s) were found to increase during the log phase of cell
growth and to reach a maximum level at confluence . These endothelial cells
exhibited morphological phenotypes comparable to those of transformed cells
when grown in the presence of acid-treated fetal calf, dog, or human serum .
Furthermore, they demonstrated anchorage independent growth, and large colo-
nies were formed in semisolid media . Spontaneous neoplastic transformation of
these cells was excluded by karyotypic analysis, lack of tumorigenicity in athymic
nude mice, and limited lifespan in culture. Cell clones isolated from colonies
grown in agarose demonstrated the same growth characteristics and proteolytic
activity as before plating in agarose . High fibrinolytic activity, morphological
changes in the appropriate serum, and growth in semisolid media may therefore
be indicative of the migratory and/or invasive capacity of both nontransformed
endothelial cells as well as tumor cells .
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Anchorage dependence and spreading on a solid
substrate are thought to be the critical prerequisites
for growth of nontransformed fibroblastic and
epithelial cells in vitro . The loss of anchorage
dependence of growth has been considered as
evidence for neoplastic transformation . Growth in
semisolid media has, therefore, become a widely
used in vitro test for neoplastic transformation of
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fibroblastic and epithelial cells . Furthermore, the
loss of anchorage dependence of growth has been
linked to an increased production of plasminogen
activator by transformed cells (20, 23, 34) .
Production of plasminogen activator is not in
itself a general marker for neoplastic transforma-
tion since a number ofnormal cells such as kidney
and lung cells (23), activated macrophages (42),
mouse blastocysts (40), stimulated ovarian granu-
losa cells (3), and granulocytes (16) also produce
plasminogen activators . However, the amount of
281proteases produced by most other normal mesen-
chymal cells is low compared to their transformed
counterparts . Vascular endothelial cells have been
shown by histochemical techniques (41) and by
vessel perfusion (1) to produce plasminogen acti-
vator. It has also been demonstrated that during
the vascularization state of tissue repair, fibrino-
lytic activity is high but disappears with the invo-
lution of blood vessels (21, 32). More recently,
Buonassisi and Venter (7) and Loskutoff and Ed-
gington (25) have reported that cultured rabbit
endothelial cells ofvenous and arterial origin pro-
duce plasminogen activator in vitro, although the
levels of this protease were low when compared to
transformed cells .
The ability of transformed cells to grow in soft
agar often correlates with the production of plas-
minogen activator (23, 34) . Since endothelial cells
produce plasminogen activator in vitro, it seemed
of interest to test whether or not these cells would
also grow in soft agar. With the exception of
chondrocytes (17) and bone marrow cells (6, 28),
no other normal cells have been reported to pro-
liferate without anchorage to a solid substrate.
Furthermore, the typical morphological growth
patterns of SV-40 transformed hamster embryo
fibroblasts have been correlated with high plas-
minogen activator-plasmin activity, and similar
morphological changes were observed in normal
hamster fibroblasts when cocultivated with their
virally transformed counterparts (31) .
This paper documents the production and se-
cretion of plasminogen activator by bovine aortic
endothelial cells, their ability to grow in soft agar,
and their different morphology in various sera .
The observed characteristics suggest a correlation
with the migratory and/or invasive potential com-
mon to both normal endothelial cells and tumor
cells .
MATERIALS AND METHODS
Culture and Cloning of Bovine Endothelial
Cells
Endothelial cell suspensions, essentially free of other cell
types, were obtained from thoracic aortae of 1- to 2-d-old calves
by the method of Eisenstein et al . (I1). These procedures gave a
yield of 1 .5-2 .5 x 106cells/aorta. The cellswere plated in 75-cm'
plastic culture flasks (Falcon, Oxnard, Calif.) in RPMI 1640
medium(GIBCO, Santa Clara, Calif.) containing 20mM HEPES
buffer and supplemented with 20% fetal calf serum (Microbio-
logical Associates, Walkersville, Md .), 100 U/ml penicillin and
streptomycin and incubated at 37°C in a humidified 5% COs-air
atmosphere. Nonadherent cells were then removed by change of
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the culture medium after 30 min. Subcultures in a 1 :10 dilution
were obtained by trypsinization (trypsin-EDTA llXJ, GIBCO)
of the cells at near confluency. Population doubling levels were
calculated from the number of cells harvested compared to the
number of cells plated . Gross contamination by other cell types
was excluded by analysis ofthe cells grown on cover slides for
the presence of cytoplasmic Factor VIII Antigen (4) . Monospe-
cific rabbit antiserum to bovine Factor VIII, kindly provided by
Dr . Edward Kirby, Temple University, Philadelphia, Penn., was
used in a 1 :40 to 1 :80 dilution and Fluorochrome conjugated
antiserum to rabbit immunoglobulins (Behring Diagnostics,
Summerville, N. J.), in a l:5 dilution .
Clones of the endothelial cell strains were obtained either by
growing single cells in microwells or by plating 25-100 cells
suspended in RPMI 1640 containing 20% fetal calfserum in 60-
mm tissue culture dishes coated with purified fibrin (2 Pg/cm2
) .
Cultures were fed once a week until colonies of 4- to 5-mm
diameterwere observed (after 2-3 wk) . Single colonies were then
ring isolated, trypsinized, andgrown up to mass cultures. Cells
were identified as ofendothelial origin by morphological criteria
at confluence and the assay for cytoplasmic Factor VIII Antigen .
Culture of Bovine Smooth Muscle Cells
After removal of the endothelial cells (see above) from the
aorta, small pieces of the inner layer ofthe vessel were plated in
60-mm plasticdishes (Falcon) in the presence of2ml ofthe same
growth medium as bovine endothelial cells . 7-10 d later, out-
growing smooth muscle cells were ring isolated, trypsinized, and
grown up to mass culture (36) .
Culture ofHuman Endothelial Cells
Primary cultures of human endothelial cells were derived
from the vein of the umbilical cord.HUC strain I was a kind gift
of David Loskutoff, Scripps Clinic, La Jolla, Calif . HUC strain
II was obtained as described by Jaffe et al . (18) . The cells were
grown in the same growth medium as the bovine endothelial cells
except that fibroblast growth factor wasadded (l5) at a concen-
tration of 1 pg/ml medium. All cell cultures used were routinely
checked every 6-8 wk for mycoplasma contamination by the
DAPI technique (37). DAPI (4'-6-diamidino-2-phenylindole)
was a kind gift of Dr,O. Dann, Friederich Alexander University,
Erlangen, West Germany .
Assayfor Plasminogen Activator
Crude bovine fibrinogen (Sigma Chemical Co ., St. Louis,
Mo .) was purified by the method of Laki (22) and depleted of
plasminogen according to Mosesson (29) . Fibrinogen was then
iodinated with ' 25 1 by the method of Frisbie and Roberts (13) .
"'I-fibrin-coated culture dishes (Falcon) were prepared as pre-
viously described (19, 23). Briefly, `251-fibrinogen was diluted
with unlabeled fibrinogen to obtain a final concentration of2 lag
fibrinogen/Cm 2 with 3,000 cpm/hg for the 60-mm tissue culture
dishes (for cell-associated plasminogen activator assay) and 10
pg fibrinogen/cm' with 1,000 cpm/lug for the 35-mm dishes
(intra- and extracellular plasminogen activator assay) . Dishes
were then dried overnight at 45°C. Fibrinogen was converted
into fibrin by incubating the dishes with RPMI 1640 containing
10% fetal calfserum (as the thrombin source) for either 2h with
2ml of medium (35-mm dishes) or 4h with 5 ml ofmedium (60-
mm dishes) just before use . Bovine thrombin (Parke-Davis,
Detroit, Mich.) at a concentration of 1 NIHU/ml medium wasused instead offetal calfserum for the plasminogen dependency
assay.
Assayfor Cell-associated Plasminogen
Activator Activity
Cells at near confluence were trypsinized, washed once with
phosphate-buffered saline (PBS), and resuspended in PBS at a
concentration of2.5 x 106 cells/ml . 0.2 ml ofthis cell suspension
in 5 ml of RPMI 1640 containing 10% ofthe appropriate serum
was plated in60-mm dishes coated with'"-fibrin and incubated
at 37 1C in the presence of95% air and5% COs. Aliquots of the
supernate were taken at the indicated time intervals, and the
released radioactivity was counted in a Gammacounter 200
(Searle Analytical, Chicago, Ill .) . Plasminogen activator activity
was expressed as the percentage ofradioactivity released into the
supernate compared to the total radioactivity of "I-fibrin/dish.
A blankwas obtained in each experiment by incubating a dish
with the corresponding growth medium alone . This fibrinolytic
activity, which never exceeded 5% after 24-h incubation, was
subtracted from that obtained by incubation ofthe cells to obtain
the true fibrinolytic activity .
Secreted Plasminogen Activator Activity
Cells (5 x 10') were seeded in 60-mm culture dishes and
grown for up to 2wk after they reachedconfluence with medium
change every second day . Growth medium was removed from
cultures either in log phase of growth or at confluence, the cells
washed once with sterile PBS and then incubated for an addi-
tional 24 h in the presence of 5 ml RPMI 1640 containing no
fetal calf serum. The supernate was then harvested, centrifuged
at 1,500 rpm for 5 min to remove cells and debris, and aliquots
of the supernate were taken and assayed for the presence of
fibrinolytic activity as described below .
Intracellular Plasminogen Activator Activity
Cells grown in 60-mmdishes as described above were washed
twice withcold PBS, scraped offthe dish with a rubber policeman
in the presence ofcold PBS, and centrifuged at 1,000 g for 5min .
The cell pellet was lysed in 15 vol ofcold 0.01 MTris-HCI,pH
8.0, containing 0.5% Triton X-100. Aliquots of the postnuclear
fraction were incubated with 2 ml of 0.1 M Tris-HCl, pH 8.0,
containing 1% acid-treated, pooled human serum for 2 hon "'I-
fibrin-coated dishes (35-mm Diam) . Radioactivity of aliquots
from the supernate was determined in a Gammacounter. The
value obtained was expressed as the percentage ofthe radioactiv-
ity released by 100 Plough units of urokinase under identical
conditions, after subtraction ofthe radioactivity released by 1%
acid-treated human serum only. One unit was defined as the
amount of activity which released l0% of the urokinase activity
in 2 h at 37°C . Protein in the cell lysatewas determined according
to Lowry et al . (26), and the plasminogen activator activity was
expressed in U/mg cellular protein .
Morphological Changes
Cells (5 x 10) were plated onto regular culture dishes (60
mm) or dishes coated with purified fibrin, 2 wg/cm', and incu-
bated in the presence of RPMI 1640 medium containing either
10 or 20% fetal calf serum, 10% plasminogen-depleted fetal calf
serum, 10% dog serum, or 10%human serum . After incubation
for 24 and 48 h at 37°C in the presence of95% air and 5% COs,
the cultures were monitored for morphological changes using the
criteria of Ossowski et al. (31) .
Other Methods
Saturation density of the cells was determined by plating 5
x 10' cells in RPMI 1640 containing 20% fetal calfserum in 60-
mm dishes. Cultures were fed every second day, and cell counts
were determined using a Coulter counter (Coulter Electronics
Inc., Hialeah, Fla.) after trypsinization of duplicate cultures .
Tumorigenicity of three different cell strains was tested by
subcutaneous injection of 10' cells into nude athymic mice . The
animals were checked twice weekly during an 18-wk period for
the appearance of tumors .
Plating efficiency of the cells in soft agar and agarose was
determined by the method ofMacPherson and Montagnier (27) .
Four dishes containing 10' and 105 cells, respectively, were set
up for eachcellline . In each experiment thehuman fibrosarcoma
cell line HT 1080 (19) was plated at the same cell densities as a
positive control . 24 h after seeding, the cultures were examined
for the presence of single cell suspension. Cultures were fed
weekly with RPMI 1640 medium supplemented with l0% fetal
calf serum. After 3 wk the cultures were examined with a
stereomicroscope (x40), and colonies containing more than eight
cells were counted . Colonies were picked out with a Pasteur
pipette and grown up in regular growth medium for further
characterization of the cells growing in semisolid media. Cells
were then retested for plasminogen activator activity, chromo-
somal pattern, and for the presence of Weibel-Palade bodies
(courtesy ofDr . Weibel, University of Bern, Switzerland) .
Chromosome preparations were made accordingto Paul et al .
(33) and banded with Trypsin-Giemsa (39) . A minimum of 20
metaphases were photographed and then counted for each cell
strain analyzed, and at least five metaphases were karyotyped .
Serum was depleted of plasminogen as described by Deutsch
and Mertz (9) . The same method was used to prepare plasmin-
ogen from human serum . Acid-treated fetal calf serum was
obtained by acidifying the serum with I N HCl to pH 3.0 . The
serum was kept for 2 h at room temperature and then the pH
was readjusted to 7.4 .
RESULTS
Characterization ofEndothelial Cells
The primary cultures, subcultures, and clones
isolated from mass cultures as well as from agarose
grew with the typical cobblestone appearance of
endothelial cells (see Fig. 7B) . The cells could be
subcultured up to 22 times (-65-70 population
doublings) before starting to senesce and to die .
Overgrowth by smooth muscle cells or fibroblasts
was never observed, ruling out gross contamina-
tion by these cell types . Furthermore, >99% ofthe
cells of the primary cultures as well as ofthe clones
isolated from agarose stained positively for Factor
VIII Antigen (Fig . 1) . Bovine smooth muscle cells
and mouse fibroblasts, on the contrary, did not
stain in the presence of monospecific rabbit anti-
serum to bovine Factor VIII Antigen. The chro-
mosomal pattern of three different parental cell
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Immunofluorescence study of cultured bovine endothelial cells. Cells fixed on a coverslip
were treated with specific rabbit antiserum against bovine Factor VIII Antigenand fluorescein-conjugated
goat antirabbit globulin as outlined in MaterialsandMethods. Left, a primary culture (EC A), and right,
cells derived from a colony growing in agarose (ECA p4 SA C12) .
strains as well as of clones isolated before and after
forming colonies in agarose are shown in Table I .
All metaphases were examined from photographs
of well banded chromosomal spreads. The major-
ity of metaphases had a normal diploid chromo-
somal complement of 60 chromosomes (24) . No
chromosomal aberrations were observed in any
metaphase including rings, dicentrics or Robert-
sonian translocations. The few cells with a chro-
mosomalnumber of 58-59 or 119-120 represented
metaphases in which a random chromosome was
lost on preparation or a normal tetraploid cell,
respectively . Fig . 2 illustrates a typical normal
diploid karyotype seen in these endothelial cells .
The particular metaphase shown was obtained
from a clone which had previously been isolated
from agarose . These cell strains were also exam-
ined for tumor formationby injection of 10 7 cells/
animal into nude mice . No tumors were detected
after 18 wk of observation . This finding, together
with the chromosomal analysis, the density-de-
pendent growth (see Fig . 6A), and the limited
lifespan of the cultures excludes the possibility of
spontaneous transformation .
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TABLE I
ChromosomalAnalyses of Bovine Endothelial Cells
The chromosomes were fixed, stained, and banded with
Giemsa as described in Materials and Methods . A min-
imum of 20 metaphases were counted . EC A, EC I, and
EC IV are parental, uncloned cell strains . EC I p4 C112
was cloned at passage 4 from EC 1 . EC A p4 SA C1 2and
EC A p4 SA C1 3 are endothelial cell clones isolated from
agarose .
Cloning ofEndothelial Cells
Since the plating efficiency of single cells into
microwells was -5%, only one clone (EC I C112)
was isolated by this method . For the isolation of
all other clones, endothelial cells were seeded at a
58
No. of
59 60
chromosomes
119 120
EC A 1 2 16 - 1
EC I - 3 16 - 1
EC 1 p4 C112 1 1 18 - -
EC Ap4SAC1 2 1 1 17 - 1
EC Ap4SAC1 3 1 1 15 1 2
EC IV 1 2 17 - -FIGURE 2
￿
Karyotype of bovine endothelial cells . This normal diploid chromosomal pattern, represent-
ative for all cell strains tested, was obtained from a clone isolated from agarose (EC A p4SA C12 ) .
concentration of 25-100 cells in 60-mm tissue
culture dishes coated with fibrin . Plating efficiency
was increased up to 60% using this method, and
much larger colonies were obtained than in un-
coated control dishes (Fig . 3) .
Plasminogen Activator Activity
Plasminogen activator activity was determined
in cultures growing on
125
1-fibrin coated dishes
(= cell-associated activity), in whole cell lysates
(= intracellular activity), and in the supernatant
media of growing cultures (= secreted activity) .
The cell-associated fibrinolytic activity of three
different endothelial cell strains and several clones
in the presence of various sera as the plasminogen
source is shown in Table II . All cell strains digested
a large amount of the fibrin present on the dish
within 24 h, although considerable variations
among different cell strains were observed. The
highest proteolytic activity was consistently ob-
tained in the presence of human and dog sera
which contain high levels of plasminogen and
relatively low concentrations of inhibitors of fi-
brinolysis (23, 35). The proteolytic activity was in
general not affected by the passage number, al-
though some variations were observed and the
clones did not differ significantly from their re-
spective parental strains. Sublines isolated from
colonies which grew in soft agar exhibited high
fibrinolytic activity essentially unchanged from
their parent cell strains. Smooth muscle cells de-
rived from the same vessels did not show any
significant proteolytic activity except when incu-
bated with dog serum . Primary cultures ofhuman
endothelial cells derived from the umbilical cord
did not produce any significant fibrinolytic activity
in either fetal calf or human serum .
The kinetics of production of cell-associated
plasminogen activator by cloned endothelial cells
grownon 1251-labeled fibrin dishes in the presence
of different sera as the plasminogen source is
shown in Fig . 4 . In the presence of 10% fetal calf
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ogen and high levels of inhibitors of fibrinolysis
(23, 35), delayed fibrinolysis was observed. After
acid treatment of fetal calf serum, which removes
the inhibitors of fibrinolysis (31), fibrin digestion
was as rapid as in the presence of human or dog
serum . Almost no radioactivity was released when
the cells were grown for 24 h in the presence of
plasminogen-depleted fetal calf serum or in the
absence of any serum . Fibrinolytic activity was
restored when plasminogen was added to the cul-
ture medium (Table III).
The cell lysates demonstrated high fibrinolytic
activities which were >90% dependent upon the
presence of plasminogen (data not shown) . The
enzyme assay forplasminogen activator was linear
during 2 h of incubation in the presence of 1%
acid-treated humanserum as long as<25% of the
radioactivity was released (Fig . 5). Dilution and
mixing experiments with urokinase proved the
absence of large amounts of inhibitors in the cell
lysates .
High fibrinolytic activity which was >95% de-
pendent upon the presence of plasminogen (data
not shown) was also detected in the serum-free
supernatant growthmedium from endothelial cell
cultures. Production and secretion of plasminogen
activator was highest in resting, confluent endo-
FIGURE 3
￿
Clonal growth of endothelial cells . 50 cells suspended in 5 ml RPMI 1640 containing 20%
fetal calfserum were plated into each culture dish . Left, a dish coated with fibrin; right, an uncoated dish .
Cultures were fed once aweek and the colonies were stained with Giemsa after 2 wk .
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thelial cell cultures (Fig . 6) . Secreted protease
activity, expressed in U/10s cells per 24 h, and
intracellular protease activity, expressed in U/mg
cellular proteinincreased steadily with cell density
and reached a maximum in confluent cultures at
12-14 d after seeding. During the following 14 d
with the cultures at confluence, the enzyme activ-
ities released per 24 h remained constantly high,
indicating that maximum enzyme production oc-
curs while the cells are arrested in the G, phase of
the cell cycle .
Morphological Changes
Endothelial cells grown for24 or 48 hon fibrin-
coated culture dishes in the presence of 10 or20%
fetal calf serum showed a typical cobblestone ap-
pearance (Fig. 7) . In thepresence ofplasminogen-
depleted fetal calf serum, the cellsdemonstrated a
fibroblast-like appearance while the presence of
10% acid-treated fetal calf serum or 101 7c human
serum caused morphological changes comparable
to class I+ according to the criteria ofOssowski et
al. (31). The most striking morphological changes
were observed in the presence of 10%Q dog serum
where multilayered cell aggregates, which re-
mained attached to the surface of the culture dish,
were observed (class ++). These morphological
changes were more prominent after 48 h incuba-TABLE Il
Cell-associated Plasminogen Activator Activity ofDifferent Endothelial and Smooth Muscle Cells
5 X 10 5 cells suspended in 5 ml RPMI 1640 containing 10% of the serum indicated were seeded onto '25I-fibrin-
coated dishes and incubated at 37°C . for 24 h . Aliquots of the supernate were then taken and the released
radioactivity was counted . Fibrinolytic activity is expressed as the percentage ofthe total radioactivity present on the
dish released into the supernate. FCS = fetal calf serum, at FCS = acid-treated fetal calf serum, DS = dog serum,
HS = human serum, p = passage number when cells were cloned, and Cl = clone, EC = bovine endothelial cells,
and HUC = human endothelial cells .
tion and less striking in the absence of fibrin on
the dish .
Growth in Soft Agar and Agarose
All bovine cell strains and clones tested grew in
soft agar (data not shown) and in agarose (Table
IV), although the plating efficiency varied from
0.1 to 11 .3% after 21 d of incubation . The colony
sizes also varied considerably (8 to >256 cells/
colony) in the different cell strains, and larger
colonies were observed with higher plating effi-
ciency . A typical small colony is shown in Fig. 8 .
Table IV also demonstrates that the cloning effi-
ciency declined with increasing passage number
and, with the exception of the cell strain EC 1
which still grew in agarose at the 15th passage
(46th population doubling), all other cell strains as
well as the clones tested did not grow in agarose
after the 8-10th passage (~25-30th population
doubling) . Clones of endothelial cells derivedfrom
the aortae of fetal calves also grew in agarose
although at a low plating efficiency . The human
fibrosarcoma cells, which were plated as a positive
control, grew at a higher plating efficiency (30-
40%) than endothelial cells . The colonies grew
faster than those derived from bovine endothelial
cells, and after 3 wk growth >80% of the colonies
consisted of 250 or more cells . Bovine smooth
muscle cells and human endothelial cells derived
from the vein of the umbilical cord did not form
any colonies in either agarose or agar .
Colonies of bovine endothelial cells growing in
agarosewere isolated, cultured as monolayers, and
tested again for various parameters. Examination
of the cells by electron microscopy proved the
presence of Weibel-Palade bodies. The morphol-
ogy at confluence showed the typical cobblestone
appearance of endothelial cells, and all cells
stained positively for Factor VIII Antigens (Fig .
1) . Cell-associated, intracellular and extracellular
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Cell strain Origin
Passage
No .
Population
doublings FCS
Fibrinolytic
at FCS
activity
DS HS
EC A Newborn calf 2 7 12 47 46
4 13 35 52 51
EC A p4 Cl t Clone of EC A isolated 4 37 6 21 39 33
before growth in agarose
EC A p2 SA Ch Clones of EC A isolated 14 71 45 50 68
EC A p4 SA C1 2 after growth in agarose 2 38 29 26 54 53
EC A p4 SA C1 3 2 38 21 50
EC I Newborn calf 3 10 45 60 71
5 16 34 66 74
7 22 54 53 80 64
13 40 56 63 54 84
16 49 10 52 38
17 52 19 56 40
22 67 41 60 45
EC I p4 C1,2 Clone ofEC I 6 40 46 58
9 49 44 52 65 60
EC IV Newborn calf 3 10 38 34 58
SM A C1 2 Smooth muscle clone of 4 19 1 0 21 4
newborn calf
HUC I Human umbilical cord l 4 0 1
HUC II (vein) l 4-5 0 0FIGURE 4
￿
Cell-associated plasminogen activator activ-
ity . 5 x l05 cloned endothelial cells (EC I C112)suspended
in 5 ml RPMI 1640 containing 10% of the indicated
serum were seeded on dishes coated with t25í-fibrin and
incubated at 37°C . Samples of the supernate were taken
at the times indicated and the released radioactivity
determined. Plasminogen activator activity is expressed
as the percentage of radioactivity released into the su-
pernate compared to the total radioactivity of 1251-fibrin/
dish . The value was corrected by subtracting the fibrin-
olytic activity developed by corresponding serum . (x)
fetal calf serum; (A) acid treated fetal calf serum ; (" )
dog serum ; and (W human serum.
fibrinolytic activity was essentially the same as in
the parental cell strains (Table II) . Cytogenetic
analysis also showed the same normal diploid
chromosomal pattern as in the original cell strains
(Table I and Fig. 2) . No colony formation was
observed when the cells were replated into agarose,
probably due to aging of the cells .
DISCUSSION
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INCUBATION TIME (h)
Primary and cloned bovine endothelial cultures
obtained from the aortae of 1- to 2-d-old calves
exhibited high fibrinolytic activity in vitro which
was dependent upon the presence of plasminogen .
These results confirm the findings of Buonassisi
and Venter (7) and Loskutoffand Edgington (25)
who also detected plasminogen-dependent prote-
olytic activity in endothelial cells derived from
rabbit aorta and vena cava, respectively . The pro-
teolytic activities in our cell strains and clones
were much higher than those reported by these
authors and were comparable to those detected in
transformed cells (23) . Smooth muscle cells, the
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most likely contaminants of our primary cultures,
did not produce significant levels of plasminogen
activator . High levels of plasminogen activator
were also found in the cell lysates but, in contrast
to Loskutoff and Edgington (25), we did not find
inhibitors of fibrinolysis .
TABLE III
Plasminogen Dependency ofExpression of
Fibrinolytic Activity
"5I-fibrinogen-coated dishes wereconverted to "I-fibrin
by incubation for 4 h with thrombin (1 NIH U/ml
RPMI) . 5 x 105 cells (EC I C112) were seeded on the dish
in the presence of the growth medium containing the
indicated serum. Percent fibrinolytic activity was deter-
mined as described for Table II .
FIGURE 5
￿
Assay of plasminogen activator in lysates of
endothelial cells . Lysates of endothelial cells were incu-
bated with I% acid-treated human serum in 0.1M Tris-
HCI, pH 8.0, on 12Bí-fibrin dishes (35 mm) . The radio-
activity solubilized in 2 h at 37°C was expressed as a
percentage of the radioactivity released by 100 U of
urokinase under identical conditions . The lysates used
were obtained from the cell strain EC I (A) and its clone
EC I C1 12 (x) while the cells were at confluence.
Serum
Fibrinolytic
activity after
24 h incuba-
tion
10% Fetal calf serum 23 .5
10% Acid-treated fetal calf serum 40 .0
None 1 .1
10% Fetal calf serum plasminogen depleted 3.5
10% Fetal calf serum plasminogen reconsti- 27 .7
tutedIC
104 L
A
10 15 20 25
DAYS IN CULTURE
150
FIGURE 6
￿
Growth curve (A) and intracellular and extracellular plasminogen activator production of
endothelial cells (B) . 5 x 10 4 cells (EC I) were seeded in 60-mm culture dishes and fed every second day .
24 h before the times indicated, quadruplicate cultures were washed with PBS and kept for a further 24
h in medium without serum . Duplicate cultures of two experiments (A) were trypsinized, and the cells
were counted in a Coulter counter . Aliquots from the supernate of quadruplicate cultures were taken at
the same time for determination of secreted plasminogen activator activity per 24 h, and lysates of
duplicate cell cultures were made for the determination of intracellular protease activity as described in
Materials and Methods. The secreted plasminogen activator activity is expressed in units released/106
cells per 24 h (X-X) and the intracellular activity in U/mg protein ("-----~) . Results are meansof two
different experiments.
FIGURE 7
￿
Morphological growth patterns of endothelial cells in different sera . 5 x 10 5 cells (EC I C1,2)
suspended in 5 mlRPM1 1640 containing the appropriate serum were seeded onto 60-mm culture dishes
coated with fibrin (2 tg/cm2) and incubated for 48 h at 37°C . Cultures were then examined for
morphological changes and photographed by phase contrast microscopy. Culture medium contained 100 /0
(A) or 20% fetal calf serum (B), 10% acid-treated fetal calf serum (C) or 10% dog serum (D) .
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Plating Efficiency of Different Endothelial Cells in Agarose
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10" and 105 cells were seeded in agarose-containing RPMI 1640 medium supplemented with 10% fetal calf serum
and fed weekly. Colonies containing >8 cells after 3 wk were counted using x40 magnificationundera stereomicro-
scope . Results are means of duplicate experiments . EC A, EC I, and EC II are primary endothelial cultures; EC I
Cí12 is a clone ofEC I ; A14 Ch and A14 C1 2 are clones of fetal aortic endothelial cells; SM2 ClA is a cloned smooth
muscle cell strain obtained from the fetal calf aorta, and SM Cls is a cloned smooth muscle cell strain isolated from
the aorta of anewborn calf. HUC I and lI are primary cultures ofhuman endothelial cells derived from the vein of
the umbilical cord .
* Determined after 4 wk incubation.
FIGURE 8
￿
Colony of endothelial cells in agarose . 105 endothelial cells (EC A) were seeded in agarose as
described in Materials and Methods . The picture of the colony was taken 3 wk after seeding. x 80 .
Cell strain Origin Passage No . Generations Plating Efficiency
ECA Newborn calf 1 3 11 .3
2 7 4 .5
4 13 5 .3
EC I Newborn calf 6 19 1 .9
10 31 2 .4
12 37 0 .9
15 46 0 .6
EC I p4 C112 Newborn calf 3 30 0.1
EC II Newborn calf 6 19 1 .3
A14 Cl Fetal calf 5 29 0.1*
A14 C12 Fetal calf 5 29 0 . 1*
SM2 Cl A Fetal calf 5 21 0*
SM Cl s Newborn calf 6 23 0*
HUC I Human umbilical 1 4 0
HUC II cord 1 4-5 0Our studies show that endothelial cells secrete
large amounts of plasminogen activator. The se-
cretion of this protease increases at higher cell
densities until amaximum is reached upon conflu-
ence, and thereafter it remains constantly high.
The intracellular protease activity showed the
same behavior . In contrast to this secretion pattern,
tumor cells produce and secrete this serine protease
mainly during the logarithmic phase of growth (8) .
Furthermore, Bosmann (5) demonstrated that leu-
kemic L5178Y cells produce proteases mainly dur-
ing theM phase ofthe cell cycle, and we obtained
similar results using synchronized hamster fibro-
sarcoma cells (Lang and Jones, unpublished ob-
servations) . Since endothelial cells produce and
secrete plasminogen activator mainly at conflu-
ence (G1 phase of the cell cycle), a significant
difference of regulation of this protease may exist
between endothelial cells and tumor cells .
Typical morphological changes as observed in
SV-40 transformed hamster embryo fibroblasts
(31) were found when the endothelial cells were
grown for 24-48 h in the presence of dog, human,
or acid-treated fetal calf serum, with the most
striking changes occurring in dog serum . Although
we could not detect this morphological pattern in
normal kidney and lung cells with high fibrinolytic
activity (23), we do not believe that this phenom-
enon is strictly related to neoplastic transforma-
tion. More likely, this behavior might be correlated
with the migratory capability of these cell types as
has been observed by Zetter et al . (43) in chick
embryo fibroblasts after treatment with proteases .
Finally, we have found that calf endothelial
cells of aortic origin grow in semisolid media,
although plating efficiency as well as colony sizes
varied considerably among the various cell strains .
The plating efficiency in agarose was highest in
primary cultures and declined with increasing pas-
sage number . Plating efficiency was also lower in
the clones than in their parental cell strains, prob-
ably due to the many cell divisions necessary for
the cloning process . This finding could also indi-
cate that primary bovine endothelial cell cultures
contain subpopulations of cells which grow in
semisolid media and which are lost during subse-
quent subcultivations . Since the cells grown in
agarose retain the characteristics of endothelial
cells, it is unlikely that they represent other con-
taminating cell types although our cloning tech-
nique does not rule out this possibility with abso-
lute certainty . Furthermore, cloned bovine smooth
muscle cells, the most likely contaminating cell
type in our system, failed to grow under the same
conditions. The highly tumorigenic human fibro-
sarcoma cell line HT 1080, on the other hand,
grew at high cloning efficiency independent of
passage number and the colonies tended to be
larger than the bovine endothelial cells. We are
not aware ofany other normal cell types that form
colonies in semisolid media, aside from chondro-
cytes (17) and cells derived from the bone marrow
(6,28) .
We have also demonstrated that, in contrast to
bovine aortic endothelial cells, untransformed hu-
man endothelial cells derived from the umbilical
vein do not grow in semisolid media, confirming
the findings of Gimbrone and Fareed (14) . Fur-
thermore, like Dosne et al . (10), we were unable to
detect any plasminogen activator production by
human endothelial cells isolated from the umbili-
cal vein . These discrepancies are most likely be-
cause endothelial cells of the umbilical vein are
different insofar as they have to fulfill only a
temporary function .
High plasminogen activator production, to-
gether with anchorage independent growth, is nor-
mally associated with oncogenic transformation
(20, 23, 34), and endothelial cells of bovine aortic
origin share these two characteristics with tumor
cells. Both vascular endothelial and tumor cells
also have the capability to invade surrounding
tissues ; but, in contrast to transformed cells, en-
dothelial cells demonstrate a "controlled" inva-
siveness since they invade and vascularize tissues
only when appropriate stimuli are present (12) . It
has been demonstrated that during the process of
vascularization blood vessel growth is achieved by
proliferation and forward migration of endothelial
cells (38) . It is attractive to hypothesize that en-
dothelial cell migration is facilitated by the plas-
minogen activator-plasminogen-plasmin system,
as has been shown for tumor cells in vitro (30) .
This hypothesis is supported by high plasminogen
activator production found in other normal cells
known to have migratory capability such as acti-
vated macrophages (42), granulocytes (16), mouse
blastocysts (40), and stimulated ovarian granulosa
cells (3). Granulocytes and stimulated macro-
phages also grow in semisolid media (6, 28), while
the other cell types outlined above have not yet
been tested for anchorage independent growth .
These data suggest that growth in semisolid media
and high plasminogen activator production are
correlated with cell migration and/or invasion,
characteristics shared by certain normal and trans-
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unique feature of tumor cells .
The continuous production and secretion of
plasminogen activator by resting endothelial cells
is another importantobservation . It hasbeen spec-
ulated for years that blood vessels release this
protease continuously to prevent intravascular co-
agulation in the organism (2), and our results
support this hypothesis . Further studies are under
way to determinewhethervenous endothelial cells
also produceand secrete this protease andwhether
they produce an inhibitor as described by Losku-
toff and Edgington (25) for endothelial cells from
the vena cava of rabbits .
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